Differential regulation of H3K9/H3K14 acetylation by small molecules drives neuron-fate-induction of glioma cell

[1]  I. Simon,et al.  Mitotic H3K9ac is controlled by phase-specific activity of HDAC2, HDAC3, and SIRT1 , 2022, Life Science Alliance.

[2]  Xin-cheng Liu,et al.  Disruption of β-catenin-mediated negative feedback reinforces cAMP-induced neuronal differentiation in glioma stem cells , 2022, Cell Death & Disease.

[3]  C. Harms,et al.  The Effects of Selective Inhibition of Histone Deacetylase 1 and 3 in Huntington’s Disease Mice , 2021, Frontiers in Molecular Neuroscience.

[4]  V. Madan,et al.  Differentiation therapy of myeloid leukemia: four decades of development , 2020, Haematologica.

[5]  Sandra Reyes-Carmona,et al.  Histone H3K9 and H3K14 acetylation at the promoter of the LGALS9 gene is associated with mRNA levels in cervical cancer cells , 2020, FEBS open bio.

[6]  X. Wan,et al.  Small Molecules that Promote Self-Renewal of Stem Cells and Somatic Cell Reprogramming , 2020, Stem Cell Reviews and Reports.

[7]  Xiang Zhuang,et al.  Correction: HDAC3 Deficiency Promotes Liver Cancer through a Defect in H3K9ac/H3K9me3 Transition. , 2020, Cancer research.

[8]  Irina M. Bochkis,et al.  Hdac3, Setdb1, and Kap1 mark H3K9me3/H3K14ac bivalent regions in young and aged liver , 2019, bioRxiv.

[9]  Gary D Bader,et al.  Pathway enrichment analysis and visualization of omics data using g:Profiler, GSEA, Cytoscape and EnrichmentMap , 2019, Nature Protocols.

[10]  T. Jiang,et al.  A radiomic signature as a non-invasive predictor of progression-free survival in patients with lower-grade gliomas , 2018, NeuroImage: Clinical.

[11]  Y. Takeda,et al.  Chemical compound-based direct reprogramming for future clinical applications , 2018, Bioscience reports.

[12]  S. Legartová,et al.  HDAC1 and HDAC3 underlie dynamic H3K9 acetylation during embryonic neurogenesis and in schizophrenia-like animals , 2017, Journal of cellular physiology.

[13]  A. Hao,et al.  Effect of melatonin on neuronal differentiation requires CBP/p300-mediated acetylation of histone H3 lysine 14 , 2017, Neuroscience.

[14]  Lisa C. Wallace,et al.  Targeting Glioma Stem Cells through Combined BMI1 and EZH2 Inhibition , 2017, Nature Medicine.

[15]  Liwu Fu,et al.  Targeting VCP enhances anticancer activity of oncolytic virus M1 in hepatocellular carcinoma , 2017, Science Translational Medicine.

[16]  Yinsheng Chen,et al.  Glioblastoma stem cell differentiation into endothelial cells evidenced through live-cell imaging , 2017, Neuro-oncology.

[17]  Xiaobai Zhang,et al.  Nucleosome eviction along with H3K9ac deposition enhances Sox2 binding during human neuroectodermal commitment , 2017, Cell Death and Differentiation.

[18]  Shiyuan Cheng,et al.  The Anti-Warburg Effect Elicited by the cAMP-PGC1α Pathway Drives Differentiation of Glioblastoma Cells into Astrocytes , 2017, Cell reports.

[19]  B. Xue,et al.  Histone Deacetylase 1 (HDAC1) Negatively Regulates Thermogenic Program in Brown Adipocytes via Coordinated Regulation of Histone H3 Lysine 27 (H3K27) Deacetylation and Methylation* , 2016, The Journal of Biological Chemistry.

[20]  L. Panasci,et al.  Interferon-α/β enhances temozolomide activity against MGMT-positive glioma stem-like cells. , 2015, Oncology reports.

[21]  Qing-Yu He,et al.  ChIPseeker: an R/Bioconductor package for ChIP peak annotation, comparison and visualization , 2015, Bioinform..

[22]  R. Momparler,et al.  Targeting of cancer stem cells by inhibitors of DNA and histone methylation , 2015, Expert opinion on investigational drugs.

[23]  E. Nestler,et al.  Antidepressant action of HDAC inhibition in the prefrontal cortex , 2015, Neuroscience.

[24]  N. Jing,et al.  Dual roles of histone H3 lysine 9 acetylation in human embryonic stem cell pluripotency and neural differentiation. , 2015, The Journal of Biological Chemistry.

[25]  Jill S Barnholtz-Sloan,et al.  Whole-genome and multisector exome sequencing of primary and post-treatment glioblastoma reveals patterns of tumor evolution , 2015, Genome research.

[26]  T. Qian,et al.  Localizing seizure-susceptible brain regions associated with low-grade gliomas using voxel-based lesion-symptom mapping. , 2015, Neuro-oncology.

[27]  J. Brotchie,et al.  RGFP109, a histone deacetylase inhibitor attenuates L-DOPA-induced dyskinesia in the MPTP-lesioned marmoset: a proof-of-concept study. , 2013, Parkinsonism & related disorders.

[28]  Justin Guinney,et al.  GSVA: gene set variation analysis for microarray and RNA-Seq data , 2013, BMC Bioinformatics.

[29]  H. Kimura,et al.  H3K9 and H3K14 acetylation co-occur at many gene regulatory elements, while H3K14ac marks a subset of inactive inducible promoters in mouse embryonic stem cells , 2012, BMC Genomics.

[30]  K. Aldape,et al.  Induction of cell-cycle arrest and apoptosis in glioblastoma stem-like cells by WP1193, a novel small molecule inhibitor of the JAK2/STAT3 pathway , 2012, Journal of Neuro-Oncology.

[31]  Yan Li,et al.  Transcriptional and post‐transcriptional down‐regulation of cyclin D1 contributes to C6 glioma cell differentiation induced by forskolin , 2011, Journal of cellular biochemistry.

[32]  Weiqi Zhang,et al.  Generation of iPSCs from mouse fibroblasts with a single gene, Oct4, and small molecules , 2011, Cell Research.

[33]  P. Farnham,et al.  Using ChIP-seq technology to identify targets of zinc finger transcription factors. , 2010, Methods in molecular biology.

[34]  A. Ganesan,et al.  Epigenetic therapy: histone acetylation, DNA methylation and anti-cancer drug discovery. , 2009, Current cancer drug targets.

[35]  Yan Li,et al.  Cholera toxin induces malignant glioma cell differentiation via the PKA/CREB pathway , 2007, Proceedings of the National Academy of Sciences.

[36]  T. Theoharides,et al.  Mast cells, T cells, and inhibition by luteolin: implications for the pathogenesis and treatment of multiple sclerosis. , 2007, Advances in experimental medicine and biology.

[37]  D. Sterner,et al.  Acetylation of Histones and Transcription-Related Factors , 2000, Microbiology and Molecular Biology Reviews.